Manufacturer record
Medimark Drugs & Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Medimark Drugs & Pharmaceuticals (Uttarakhand) were declared Not of Standard Quality between September 2019 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ML25245, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup (exp Jul 2027). Drugs Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: Content. Listed in the January 2026 alert.
Records by type
4 records linked to Medimark Drugs & Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | Batch ML25245Mfg Aug 2025 · Exp Jul 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP (MEFSAN-SPAS TABLETS) | Batch MT-22202Mfg Jul 2022 · Exp Jun 2024 | Dissolution of Dicyclomine Hydrochlorid eDissolution | RDTL ChandigarhCDSCO lab | Sep 2023 |
| WARCETIZ (Cetirizine Hydrochloride Tablets IP) | Batch MT-21465Mfg Dec 2021 · Exp Nov 2023 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| Cetfast (Cetirizine Hydrochloride Tablets I.P.) | Batch MT-17533Mfg Mar 2018 · Exp Feb 2020 | AssayAssay | CDL KolkataCDSCO lab | Sep 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.